Skip to content

Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children

A Retrospective Single Center Study of the Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in PICU Hospitalized Children

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04535661
Enrollment
536
Registered
2020-09-02
Start date
2021-03-01
Completion date
2026-12-31
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbapenem-Resistant Enterobacteriaceae Infection

Brief summary

Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in China. Pediatric intensive care unit (PICU) is the high-risk area. However, data on the epidemiology of CRE in hospitalized children in PICU are limited. The objectives of this study are to characterize the risk factors for colonization or infection with CRE and describe the microbiologic characteristics of pediatric CRE isolates. The investigators will perform a single retrospective study from January 2018 to December 2019 at PICU of Children's Hospital of Fudan University .

Detailed description

The investigators intend to enroll all children who were hospitalized in pediatric intensive care unit PICU of Children's Hospital of Fudan University from January 2018 to December 2019. Children who had positive cultures for any Enterobacteriaceae species before their admission will be excluded. Children with a PICU length of day less than 48h will also be excluded. According to their clinical cultures results, they will be divided into non-CRE、CRE colonization and CRE infection. CRE was defined according to the 2015 Centers for Disease Control and Prevention (CDC) definition as an isolate resistant to imipenem, meropenem, or ertapenem. Clinical and demographic data will be collected from the electronic health record.

Interventions

None listed

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
29 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* All children hospitalized in PICU of Children's Hospital of Fudan University from January 2018 to December 2019.

Exclusion criteria

* discharge within 48 hours * patients had a positive culture for CRE before admission * incomplete clinical and demographic data

Design outcomes

Primary

MeasureTime frameDescription
mortalitywithin 28 days after they discharged from PICUThe death rate of children in 28 days after their discharged from PICU

Secondary

MeasureTime frameDescription
length of stay in PICUwithin 28 days after they discharged from PICUTime from PICU admission to discharge

Countries

China

Contacts

CONTACTGangfeng Yan
jinyi036@126.com+8615900603082
PRINCIPAL_INVESTIGATORGangfeng Yan

Children's Hospital of Fundan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026